Prasugrel versus clopidogrel in patients with acute coronary syndromes.: Results of the TRITON-TIMI 38 trial

被引:0
|
作者
Preohrazhensky, D. V.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:72 / 73
页数:2
相关论文
共 50 条
  • [21] Prasugrel versus clopidogrel in patients with acute coronary syndromes
    Wiviott, Stephen D.
    Braunwald, Eugene
    McCabe, Carolyn H.
    Montalescot, Gilles
    Ruzyllo, Witold
    Gottlieb, Shmuel
    Neumann, Franz-Joseph
    Ardissino, Diego
    De Servi, Stefano
    Murphy, Sabina A.
    Riesmeyer, Jeffrey
    Weerakkody, Govinda
    Gibson, C. Michael
    Antman, Elliott M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20): : 2001 - 2015
  • [22] Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis
    Goodnough, Lawrence T.
    Smith, Peter K.
    Levy, Jerrold H.
    Poston, Robert S.
    Short, Mary A.
    Weerakkody, Govinda J.
    LeNarz, LeRoy A.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 145 (04): : 1077 - +
  • [23] The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention: A TRITON-TIMI 38 Analysis
    O'Donoghue, Michelle L.
    Wiviott, Stephen D.
    Murphy, Sabina A.
    McCabe, Carolyn H.
    Antman, Elliott M.
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A460 - A460
  • [25] Response to Letter Regarding Article, "Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention: Results From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38"
    Mahoney, Elizabeth M.
    Wang, Kaijun
    Arnold, Suzanne V.
    Cohen, David J.
    Proskorovsky, Irina
    Wiviott, Stephen
    Antman, Elliott
    Braunwald, Eugene
    CIRCULATION, 2010, 122 (08) : E437 - E437
  • [26] Absence of an Interaction Between Drugs Metabolized by Cytochrome P450 Enzymes and the Benefit of Treatment With Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention: A TRITON-TIMI 38 Analysis
    O'Donoghue, Michelle
    Wiviott, Stephen D.
    Murphy, Sabina A.
    Bates, Eric R.
    Sabatine, Marc S.
    Mega, Jessica L.
    Desai, Nihar R.
    McCabe, Carolyn H.
    Antman, Elliott M.
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A328 - A328
  • [27] Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial
    De Servi, Stefano
    Goedicke, Jochen
    Schirmer, Andreas
    Widimsky, Petr
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2014, 3 (04) : 363 - 372
  • [28] Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes. Results of the PLATO Study
    Preobrazhensky, D. V.
    KARDIOLOGIYA, 2010, 50 (01) : 68 - 68
  • [29] REDUCTION IN REHOSPITALIZATIONS AND ASSOCIATED COSTS WITHIN 30 DAYS AFTER DISCHARGE FROM HOSPITALIZATION FOR ACUTE CORONARY SYNDROMES AND PLANNED PCI WITH PRASUGREL VS. CLOPIDOGREL: RESULTS FROM THE TRITON-TIMI 38 TRIAL FOR PATIENTS WITH NO HISTORY OF STROKE OR TIA
    Mahoney, E. M.
    Wang, K.
    Bae, J. P.
    Zhu, B.
    Marciniak, M. D.
    Effron, M. B.
    Cohen, D. J.
    VALUE IN HEALTH, 2009, 12 (07) : A336 - A336
  • [30] Does Prasugrel Provide a Clinically Important Treatment Benefit Compared with Clopidogrel? A Bayesian Analysis of TRITON-TIMI 38
    Kaul, Sanjay
    Shah, Prediman K.
    Diamond, George A.
    CIRCULATION, 2008, 118 (18) : S819 - S819